Logo image of ACO-Y.CA

ATCO LTD -CL 'II' (ACO-Y.CA) Stock Fundamental Analysis

Canada - Toronto Stock Exchange - TSX:ACO-Y - CA0467895094 - Common Stock

60 CAD
-0.52 (-0.86%)
Last: 12/12/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, ACO-Y scores 4 out of 10 in our fundamental rating. ACO-Y was compared to 19 industry peers in the Multi-Utilities industry. Both the profitability and the financial health of ACO-Y get a neutral evaluation. Nothing too spectacular is happening here. ACO-Y has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

ACO-Y had positive earnings in the past year.
ACO-Y had a positive operating cash flow in the past year.
ACO-Y had positive earnings in each of the past 5 years.
Each year in the past 5 years ACO-Y had a positive operating cash flow.
ACO-Y.CA Yearly Net Income VS EBIT VS OCF VS FCFACO-Y.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

1.2 Ratios

Looking at the Return On Assets, with a value of 1.55%, ACO-Y is in line with its industry, outperforming 42.86% of the companies in the same industry.
ACO-Y's Return On Equity of 9.08% is amongst the best of the industry. ACO-Y outperforms 85.71% of its industry peers.
ACO-Y's Return On Invested Capital of 3.73% is on the low side compared to the rest of the industry. ACO-Y is outperformed by 76.19% of its industry peers.
ACO-Y had an Average Return On Invested Capital over the past 3 years of 3.92%. This is in line with the industry average of 3.74%.
Industry RankSector Rank
ROA 1.55%
ROE 9.08%
ROIC 3.73%
ROA(3y)1.62%
ROA(5y)1.41%
ROE(3y)9.17%
ROE(5y)7.94%
ROIC(3y)3.92%
ROIC(5y)3.81%
ACO-Y.CA Yearly ROA, ROE, ROICACO-Y.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

ACO-Y has a Profit Margin (8.38%) which is in line with its industry peers.
ACO-Y's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 24.56%, ACO-Y is in line with its industry, outperforming 42.86% of the companies in the same industry.
In the last couple of years the Operating Margin of ACO-Y has declined.
ACO-Y's Gross Margin of 74.90% is in line compared to the rest of the industry. ACO-Y outperforms 42.86% of its industry peers.
ACO-Y's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 24.56%
PM (TTM) 8.38%
GM 74.9%
OM growth 3Y2.6%
OM growth 5Y-3.18%
PM growth 3Y14.9%
PM growth 5Y-4.41%
GM growth 3Y-0.25%
GM growth 5Y-1.16%
ACO-Y.CA Yearly Profit, Operating, Gross MarginsACO-Y.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ACO-Y is destroying value.
ACO-Y has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for ACO-Y has been reduced compared to 5 years ago.
Compared to 1 year ago, ACO-Y has a worse debt to assets ratio.
ACO-Y.CA Yearly Shares OutstandingACO-Y.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ACO-Y.CA Yearly Total Debt VS Total AssetsACO-Y.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

Based on the Altman-Z score of 0.79, we must say that ACO-Y is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ACO-Y (0.79) is better than 85.71% of its industry peers.
ACO-Y has a debt to FCF ratio of 27.90. This is a negative value and a sign of low solvency as ACO-Y would need 27.90 years to pay back of all of its debts.
ACO-Y has a Debt to FCF ratio of 27.90. This is amongst the best in the industry. ACO-Y outperforms 95.24% of its industry peers.
A Debt/Equity ratio of 2.64 is on the high side and indicates that ACO-Y has dependencies on debt financing.
ACO-Y's Debt to Equity ratio of 2.64 is on the low side compared to the rest of the industry. ACO-Y is outperformed by 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.64
Debt/FCF 27.9
Altman-Z 0.79
ROIC/WACC0.73
WACC5.13%
ACO-Y.CA Yearly LT Debt VS Equity VS FCFACO-Y.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 1.81 indicates that ACO-Y should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.81, ACO-Y belongs to the top of the industry, outperforming 95.24% of the companies in the same industry.
A Quick Ratio of 1.66 indicates that ACO-Y should not have too much problems paying its short term obligations.
The Quick ratio of ACO-Y (1.66) is better than 95.24% of its industry peers.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 1.66
ACO-Y.CA Yearly Current Assets VS Current LiabilitesACO-Y.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

ACO-Y shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.19%, which is quite good.
Measured over the past 5 years, ACO-Y shows a small growth in Earnings Per Share. The EPS has been growing by 6.10% on average per year.
ACO-Y shows a small growth in Revenue. In the last year, the Revenue has grown by 7.75%.
Measured over the past years, ACO-Y shows a small growth in Revenue. The Revenue has been growing by 0.98% on average per year.
EPS 1Y (TTM)10.19%
EPS 3Y8.59%
EPS 5Y6.1%
EPS Q2Q%13.58%
Revenue 1Y (TTM)7.75%
Revenue growth 3Y4.84%
Revenue growth 5Y0.98%
Sales Q2Q%6.09%

3.2 Future

ACO-Y is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.04% yearly.
ACO-Y is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.61% yearly.
EPS Next Y9.29%
EPS Next 2Y5.14%
EPS Next 3Y5.04%
EPS Next 5YN/A
Revenue Next Year-5%
Revenue Next 2Y-1%
Revenue Next 3Y0.61%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ACO-Y.CA Yearly Revenue VS EstimatesACO-Y.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
ACO-Y.CA Yearly EPS VS EstimatesACO-Y.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 13.22 indicates a correct valuation of ACO-Y.
The rest of the industry has a similar Price/Earnings ratio as ACO-Y.
Compared to an average S&P500 Price/Earnings ratio of 26.92, ACO-Y is valued rather cheaply.
The Price/Forward Earnings ratio is 12.65, which indicates a correct valuation of ACO-Y.
The rest of the industry has a similar Price/Forward Earnings ratio as ACO-Y.
ACO-Y's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.46.
Industry RankSector Rank
PE 13.22
Fwd PE 12.65
ACO-Y.CA Price Earnings VS Forward Price EarningsACO-Y.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

ACO-Y's Enterprise Value to EBITDA ratio is in line with the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as ACO-Y.
Industry RankSector Rank
P/FCF 14.5
EV/EBITDA 8.55
ACO-Y.CA Per share dataACO-Y.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

ACO-Y's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.42
PEG (5Y)2.16
EPS Next 2Y5.14%
EPS Next 3Y5.04%

6

5. Dividend

5.1 Amount

ACO-Y has a Yearly Dividend Yield of 3.63%. Purely for dividend investing, there may be better candidates out there.
With a Dividend Yield of 3.63, ACO-Y pays less dividend than the industry average, which is at 5.05. 90.48% of the companies listed in the same industry pay a better dividend than ACO-Y!
Compared to an average S&P500 Dividend Yield of 2.00, ACO-Y pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.63%

5.2 History

The dividend of ACO-Y has a limited annual growth rate of 3.93%.
ACO-Y has paid a dividend for at least 10 years, which is a reliable track record.
ACO-Y has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)3.93%
Div Incr Years31
Div Non Decr Years34
ACO-Y.CA Yearly Dividends per shareACO-Y.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

52.20% of the earnings are spent on dividend by ACO-Y. This is a bit on the high side, but may be sustainable.
ACO-Y's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP52.2%
EPS Next 2Y5.14%
EPS Next 3Y5.04%
ACO-Y.CA Yearly Income VS Free CF VS DividendACO-Y.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M
ACO-Y.CA Dividend Payout.ACO-Y.CA Dividend Payout, showing the Payout Ratio.ACO-Y.CA Dividend Payout.PayoutRetained Earnings

ATCO LTD -CL 'II'

TSX:ACO-Y (12/12/2025, 7:00:00 PM)

60

-0.52 (-0.86%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)11-07 2025-11-07/bmo
Earnings (Next)02-25 2026-02-25
Inst Owners28.28%
Inst Owner ChangeN/A
Ins Owners0.68%
Ins Owner ChangeN/A
Market Cap6.73B
Revenue(TTM)5.14B
Net Income(TTM)431.00M
Analysts78.57
Price Target57.49 (-4.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.63%
Yearly Dividend1.96
Dividend Growth(5Y)3.93%
DP52.2%
Div Incr Years31
Div Non Decr Years34
Ex-Date12-04 2025-12-04 (0.5045)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.14%
Min EPS beat(2)-3.78%
Max EPS beat(2)8.05%
EPS beat(4)3
Avg EPS beat(4)2.22%
Min EPS beat(4)-3.78%
Max EPS beat(4)8.05%
EPS beat(8)7
Avg EPS beat(8)4.37%
EPS beat(12)9
Avg EPS beat(12)2.66%
EPS beat(16)12
Avg EPS beat(16)4.06%
Revenue beat(2)0
Avg Revenue beat(2)-9.84%
Min Revenue beat(2)-17.7%
Max Revenue beat(2)-1.99%
Revenue beat(4)0
Avg Revenue beat(4)-9.73%
Min Revenue beat(4)-18.52%
Max Revenue beat(4)-0.7%
Revenue beat(8)0
Avg Revenue beat(8)-11.91%
Revenue beat(12)0
Avg Revenue beat(12)-10.29%
Revenue beat(16)1
Avg Revenue beat(16)-9.26%
PT rev (1m)0%
PT rev (3m)-1.53%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.27%
EPS NY rev (1m)0.93%
EPS NY rev (3m)1.65%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.42%
Valuation
Industry RankSector Rank
PE 13.22
Fwd PE 12.65
P/S 1.31
P/FCF 14.5
P/OCF 2.76
P/B 1.42
P/tB 1.99
EV/EBITDA 8.55
EPS(TTM)4.54
EY7.57%
EPS(NY)4.74
Fwd EY7.9%
FCF(TTM)4.14
FCFY6.9%
OCF(TTM)21.76
OCFY36.26%
SpS45.88
BVpS42.35
TBVpS30.16
PEG (NY)1.42
PEG (5Y)2.16
Graham Number65.77
Profitability
Industry RankSector Rank
ROA 1.55%
ROE 9.08%
ROCE 4.79%
ROIC 3.73%
ROICexc 3.92%
ROICexgc 4.15%
OM 24.56%
PM (TTM) 8.38%
GM 74.9%
FCFM 9.02%
ROA(3y)1.62%
ROA(5y)1.41%
ROE(3y)9.17%
ROE(5y)7.94%
ROIC(3y)3.92%
ROIC(5y)3.81%
ROICexc(3y)4.06%
ROICexc(5y)3.97%
ROICexgc(3y)4.27%
ROICexgc(5y)4.16%
ROCE(3y)5.04%
ROCE(5y)4.9%
ROICexgc growth 3Y1.58%
ROICexgc growth 5Y-6.25%
ROICexc growth 3Y1.11%
ROICexc growth 5Y-6.55%
OM growth 3Y2.6%
OM growth 5Y-3.18%
PM growth 3Y14.9%
PM growth 5Y-4.41%
GM growth 3Y-0.25%
GM growth 5Y-1.16%
F-Score7
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 2.64
Debt/FCF 27.9
Debt/EBITDA 5.96
Cap/Depr 234.56%
Cap/Sales 38.4%
Interest Coverage 2.33
Cash Conversion 115.87%
Profit Quality 107.66%
Current Ratio 1.81
Quick Ratio 1.66
Altman-Z 0.79
F-Score7
WACC5.13%
ROIC/WACC0.73
Cap/Depr(3y)212.07%
Cap/Depr(5y)195.52%
Cap/Sales(3y)33.77%
Cap/Sales(5y)31.75%
Profit Quality(3y)134.57%
Profit Quality(5y)187.54%
High Growth Momentum
Growth
EPS 1Y (TTM)10.19%
EPS 3Y8.59%
EPS 5Y6.1%
EPS Q2Q%13.58%
EPS Next Y9.29%
EPS Next 2Y5.14%
EPS Next 3Y5.04%
EPS Next 5YN/A
Revenue 1Y (TTM)7.75%
Revenue growth 3Y4.84%
Revenue growth 5Y0.98%
Sales Q2Q%6.09%
Revenue Next Year-5%
Revenue Next 2Y-1%
Revenue Next 3Y0.61%
Revenue Next 5YN/A
EBIT growth 1Y25.67%
EBIT growth 3Y7.57%
EBIT growth 5Y-2.22%
EBIT Next Year409.03%
EBIT Next 3Y77.89%
EBIT Next 5YN/A
FCF growth 1Y1.09%
FCF growth 3Y-8.79%
FCF growth 5Y2.94%
OCF growth 1Y16.42%
OCF growth 3Y5.63%
OCF growth 5Y7.34%

ATCO LTD -CL 'II' / ACO-Y.CA FAQ

Can you provide the ChartMill fundamental rating for ATCO LTD -CL 'II'?

ChartMill assigns a fundamental rating of 4 / 10 to ACO-Y.CA.


What is the valuation status of ATCO LTD -CL 'II' (ACO-Y.CA) stock?

ChartMill assigns a valuation rating of 3 / 10 to ATCO LTD -CL 'II' (ACO-Y.CA). This can be considered as Overvalued.


Can you provide the profitability details for ATCO LTD -CL 'II'?

ATCO LTD -CL 'II' (ACO-Y.CA) has a profitability rating of 4 / 10.


What is the expected EPS growth for ATCO LTD -CL 'II' (ACO-Y.CA) stock?

The Earnings per Share (EPS) of ATCO LTD -CL 'II' (ACO-Y.CA) is expected to grow by 9.29% in the next year.


Can you provide the dividend sustainability for ACO-Y stock?

The dividend rating of ATCO LTD -CL 'II' (ACO-Y.CA) is 6 / 10 and the dividend payout ratio is 52.2%.